Clinical and translational studies have shown that HU therapy not only reduces leukocytosis but also downregulates inflammatory cytokines such as TNF-α, IL-8, and soluble adhesion molecules, thereby lowering neutrophil activation and vascular adhesion 45. The gene discussed is CXCL8; the disease is Increased total leukocyte count.